Diabetes Devices Market Studies Research 2017 Detailed Analysis of Restrain and Growth Factors
Study on Diabetes
Devices Market by Infinium Global research is comprehensive
presentation of qualitative and quantitative research to identify key trends,
growth prospects, drivers, restraints and opportunities in the Global market.
The report also deep dives into the sub-segments of Diabetes Devices Market by
molecule (biologics, small molecules), route of administration (oral,
parenteral, topical), dosage forms (solid, liquid, EMI-solid ), mechanism of
action (TNF inhibitors, PDE4 inhibitors, il blocker) through main geographies
in the Global Market such as North America, Europe, Asia-Pacific and RoW.
Browse through over 100 tables and figures to get complete view of the global
and regional markets of Diabetes Devices over the period of 2017 to 2023.
The report on Asia-Pacific
Diabetes Devices market provides qualitative and quantitative analysis for the
period of 2015 to 2023. According to report the Asia-Pacific Diabetes
Devices market is expected to grow at a CAGR between 6.1% and 6.5% over
the forecast period of 2017 – 2023.The Asia-Pacific market for diabetes devices
was valued at USD 3.2 billion in 2015 and is expected to reach around USD XX
billion by 2023.
Market
Insights:
The report identified that
Asia-Pacific Diabetes Devices is driven by factors such as Growing demand from
emerging markets and supportive government initiatives, Increasing demand for
minimally invasive and non-invasive treatment and monitoring devices, and, Rise
in base of geriatric population, growing awareness about the technologically
advanced products among the population. While the restraining factors include
High Costs Associated to the Diagnosis and Treatment of Diabetes, and Lack of
Reimbursement Policies. Further, the report identifies the opportunities in the
world market as Increased Awareness on Diabetes Devices, and Healthy Growth in
the Active Wound Care Market.
Segments
Covered
The report on Asia-Pacific
Diabetes Devices market covers type of device segment. The type of device
segment includes Monitoring devices and Treatment devices. Monitoring devices
such as Self-monitoring blood glucose and Continuous blood glucose monitoring.
Treatment devices such as Manual Injection and Pumps.
Companies Covered
Abbott Laboratories
Becton, Dickinson and Company
Johnson & Johnson
Medtronic
Ascensia
DexCom
Insulet
Sanofi
Novo Nordisk
Roche
Becton, Dickinson and Company
Johnson & Johnson
Medtronic
Ascensia
DexCom
Insulet
Sanofi
Novo Nordisk
Roche
Key topics covered:
1. Preface
2. Executive summary
3. Asia-Pacific Diabetes Devices
market Overview
4. Asia-Pacific Diabetes Devices
market Analysis by type of device 2017 – 2023
5. Asia-Pacific Diabetes Devices
market Analysis, by Countries 2017 – 2023
6. Companies Covered
Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_diabetes_devices_market
Comments
Post a Comment